Effectiveness of thrombosis prevention with a low molecular weight heparin preparation in gynaecological patients undergoing surgery: an open study.

Curr Med Res Opin

Divisione di Ostetricia e Ginecologia, Ospedale per gli Infermi, Rimini, Italy.

Published: June 1989

An open study was carried out in 92 patients to assess the effectiveness of a new low molecular weight heparin in preventing thromboembolic events after gynaecological surgery. The drug was administered subcutaneously 2 hours before the operation and afterwards once a day for 7 days in doses of either 7500 U. aXa/day or 15,000 U. aXa/day according to thrombosis risk and other variables. Only 3 patients developed deep vein thrombosis and none pulmonary embolism. There was no evidence of increased haemorrhage risk and few haematomas were noted at the wound or injection site. Laboratory data showed a marked increase in plasma inhibition of activated Factor X from Day 1 and this increase was maintained throughout the study period.

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007998909110136DOI Listing

Publication Analysis

Top Keywords

low molecular
8
molecular weight
8
weight heparin
8
open study
8
effectiveness thrombosis
4
thrombosis prevention
4
prevention low
4
heparin preparation
4
preparation gynaecological
4
gynaecological patients
4

Similar Publications

Understanding charge transport in semiconductor quantum dot (QD) assemblies is important for developing the next generation of solar cells and light-harvesting devices based on QD technology. One of the key factors that governs the transport in such systems is related to the hybridization between the QDs. Recent experiments have successfully synthesized QD molecules, arrays, and assemblies by directly fusing the QDs, with enhanced hybridization leading to high carrier mobilities and coherent band-like electronic transport.

View Article and Find Full Text PDF

Purpose: We designed a CD19-targeted chimeric antigen receptor (CAR) comprising a calibrated signaling module, termed 1XX, that differs from that of conventional CD28/CD3ζ and 4-1BB/CD3ζ CARs. Preclinical data demonstrated that 1XX CARs generated potent effector function without undermining T-cell persistence. We hypothesized that 1XX CAR T cells may be effective at low doses and elicit minimal toxicities.

View Article and Find Full Text PDF

Endometrial cancer (UCEC) is the most prevalent gynecological malignancy in high-income countries, and its incidence is rising globally. Although early-stage UCEC can be treated with surgery, advanced cases have a poor prognosis, highlighting the need for effective molecular biomarkers to improve diagnosis and prognosis. In this study, we analyzed mRNA and miRNA sequencing data from UCEC tissues and adjacent non-cancerous tissues from the TCGA database.

View Article and Find Full Text PDF

Colon cancer, as a highly prevalent malignant tumor globally, poses a significant threat to human health. In recent years, ferroptosis and cuproptosis, as two novel forms of cell death, have attracted widespread attention for their potential roles in the development and treatment of colon cancer. However, the investigation into the subtypes and their impact on the survival of colon cancer patients remains understudied.

View Article and Find Full Text PDF

Cognitive dysfunction in Alzheimer's disease results from a complex interplay of various pathological processes, including the dysregulation of key enzymes such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and monoamine oxidase B (MAO-B). This study proposes and designs a series of novel molecules derived from 8-hydroxyquinoline (Azo-8HQ) as potential multi-target lead candidates for treating AD. An exhaustive in silico analysis was conducted, encompassing docking studies, ADMET analysis, density functional theory (DFT) studies, molecular dynamics simulations, and subsequent MM-GBSA calculations to examine the pharmacological potential of these molecules with the specific targets of interest.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!